{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "SHIELD THERAPEUT. LS-,015", "longName": "Shield Therapeutics plc", "messageBoardId": "finmb_115221091", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "marketState": "REGULAR", "regularMarketChangePercent": -0.62111926, "regularMarketPrice": 0.08, "firstTradeDateMilliseconds": 1457074800000, "priceHint": 4, "regularMarketChange": -0.000500001, "regularMarketTime": 1683871418, "regularMarketDayHigh": 0.08, "regularMarketDayRange": "0.08 - 0.08", "regularMarketDayLow": 0.08, "regularMarketVolume": 65000, "regularMarketPreviousClose": 0.0805, "bid": 0.0805, "ask": 0.094, "bidSize": 5000, "askSize": 5000, "fullExchangeName": "Frankfurt", "financialCurrency": "GBP", "regularMarketOpen": 0.08, "averageDailyVolume3Month": 4031, "averageDailyVolume10Day": 8926, "fiftyTwoWeekLowChange": 0.027999997, "fiftyTwoWeekLowChangePercent": 0.53846145, "fiftyTwoWeekRange": "0.052 - 0.194", "fiftyTwoWeekHighChange": -0.11400001, "fiftyTwoWeekHighChangePercent": -0.5876289, "fiftyTwoWeekLow": 0.052, "fiftyTwoWeekHigh": 0.194, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.16, "twoHundredDayAverageChangePercent": -0.036956836, "sharesOutstanding": 585670016, "bookValue": 0.151, "fiftyDayAverage": 0.07276, "fiftyDayAverageChange": 0.0072399974, "fiftyDayAverageChangePercent": 0.099505186, "twoHundredDayAverage": 0.08307, "twoHundredDayAverageChange": -0.0030700043, "marketCap": 49004160, "priceToBook": 0.5298013, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "symbol": "1JS.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Northern Design Centre", "address2": "Baltic Business Quarter", "city": "Gateshead", "zip": "NE8 3DF", "country": "United Kingdom", "phone": "44 1915 118 500", "website": "https://www.shieldtherapeutics.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Shield Therapeutics plc, a specialty pharmaceutical company, engages in the development and commercialization of clinical stage pharmaceuticals to treat unmet medical needs. The company's lead product is Accrufer/Feraccru, a non-salt based oral therapy for the treatment of iron deficiency with or without anemia in adults. It also develops PT20, a novel iron-based phosphate binder that has completed its Phase II pivotal study for the treatment of hyperphosphatemia in patients with chronic kidney disease. The company was founded in 2008 and is based in Gateshead, the United Kingdom.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Gregory P. Madison", "age": 54, "title": "CEO & Exec. Director", "yearBorn": 1968, "fiscalYear": 2021, "totalPay": {"raw": 545496, "fmt": "545.5k", "longFmt": "545,496"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Christian  Schweiger M.D., Ph.D.", "age": 55, "title": "Co-Founder & Non Exec. Director", "yearBorn": 1967, "fiscalYear": 2021, "totalPay": {"raw": 63053, "fmt": "63.05k", "longFmt": "63,053"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Hans-Peter  Rudolf", "title": "Chief Financial Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Lucy  Huntington-Bailey", "title": "Gen. Counsel & Company Sec.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Suzanne  Wood", "title": "Group HR Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Carol  Akinola", "title": "Head of Pharmacovigilance & Medical Information", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Andrew  Hurley", "age": 53, "title": "Chief Commercial Officer", "yearBorn": 1969, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}